Sep 13, 2023 / 06:55PM GMT
Unidentified Analyst -
Hi. Good afternoon. I'm Fernando Marin, Executive Director in the Life Sciences Tools and Diagnostics coverage team at Morgan Stanley. Before we begin, I'd like to remind you that important disclosure information can be found at the Morgan Stanley research disclosure website. If you have any questions, flitch out to your Morgan Stanley sales representative.
With that, it's my pleasure to hold Azenta today. Speaking on behalf of the company is CFO, Lindon Robertson. Lindon, thanks for joining us today.
Lindon G. Robertson - Azenta, Inc. - Executive VP & CFO
It's our pleasure. Thank you for having us.
Questions and Answers:
Unidentified Analyst -And to start, maybe can you just provide the audience with a brief overview of the company's recent trajectory and key accomplishments and opportunities going forward?
Lindon G. Robertson - Azenta, Inc. - Executive VP & CFO
Yes, really happy to. Azenta is a business that's really focused on sample-based